作为设计用于siRNA输送的双功能抗体的模块,Staufen dsRNA结合域
Yahui Liu1, Yan Zheng1, Ruolin Xu1
1Department of Pharmaceutical Engineering, School of Pharmaceutical Sciences, Wuhan University, Wuhan, Hubei 430071, China.
Nucleic acids research
|January 22, 2026
概括
双功能抗体将小干扰RNA (siRNA) 结合而非结合,使各种细胞类型的基因沉默成为可能. 提高siRNA功效可以提高疗效,但高亲和度结合对于治疗应用至关重要.
科学领域:
- 生物技术是生物技术.
- 分子生物学分子生物学
- 药物运输 药物运输 药物运输
背景情况:
- 抗体-siRNA结合体提供了额外肝脏siRNA传递的潜力.
- 目前的结合式设计在目标扩展和结构完整性方面存在局限性.
研究的目的:
- 开发一个模块化的双功能抗体系统,用于siRNA连接.
- 为了实现一对一的抗体-siRNA配对,以提高功能和目标扩展.
主要方法:
- 设计了一种双功能抗体系统,使用非化siRNA招募模块 (Staufen1 dsRBD34).
- 研究的siRNA招募独立于基因修改.
- 评估了多种细胞类型的基因沉默疗效,以1:1的静电测量.
- 功能化siRNA与小分子增强剂,以增加沉默功效.
- 通过阿金扫描对dsrna结合域进行了亲和力成熟.
主要成果:
- 双功能抗体系统成功地招募了siRNA,并使不同细胞类型的基因沉默成为可能.
- 小分子增强剂增加了七倍的沉默功效 (IC50从200到28nM).
- 亲和力成熟增加了dsRBD34亲和力32倍,但没有改善静音或血稳定性.
- 循环中的硫酸氨基甘油 (GAG) 的竞争影响了药理动力学,阻碍了体内评估.
结论:
- 双功能抗体为siRNA输送提供了一个有前途的平台,使目标扩张和功能化成为可能.
- 虽然siRNA增强可以提高功效,但超高亲和度dsRNA结合域对于实现体内治疗潜力至关重要.
- 需要进一步的研究来克服循环GAG所带来的药理动力学挑战.
相关概念视频
siRNA - Small Interfering RNAs
18.4K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.4K
Conservation of Protein Domains Over Different Proteins
14.1K
Protein domains are small structurally independent units that are part of a single amino acid chain. Although these domains are often structurally independent, they may rely on synergistic effects to perform their functions as part of a larger protein. Protein domains may be conserved within the same organism, as well as across different organisms.
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
14.1K
Antibody Structure
65.4K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
65.4K
Conserved Binding Sites
5.0K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
5.0K
The Equilibrium Binding Constant and Binding Strength
14.9K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
14.9K
Group Design
10.3K
The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between...
10.3K


